Below you'll find a list of all posts that have been categorized as “Cannabis Treatments”
Dedi Meiri, PhD runs a lab at the Technion Israel Institute of Technology that investigates the anti-tumor effects of cannabinoids. More specifically, his team identifies which combination of cannabinoids can kill cancer cells. Most notably, his team identified three specific cannabinoids that kill leukemia cells and that formulation is currently being tested in a clinical trial in Israel. Dr. Meiri …
Michael Levinsohn is a criminal and civil defense attorney with 20 years of experience representing people in all areas of the cannabis industry, including patients, cultivators, retailers, and healthcare providers. We catch up on new developments in cannabis law since last we spoke, including Ryan’s Law, which requires California hospitals providing palliative care allow terminally ill patients to use cannabis …
John Malanca co-founded United Patients Group (UPG), a trusted resource and leader in medical cannabis information and education for patients, physicians, pharmacists, governments, and organizations, both domestically and internationally. UPG also acts as a virtual hand for patients and their loved ones struggling with chronic and terminal illnesses by helping them navigate through this ever-changing industry. At CannMed 2021, John …
Dr. Michelle Shuffett is an accomplished healthcare executive, marketing strategist, speaker, and wellness enthusiast with 20+ years of experience encompassing a unique blend of clinical medicine, communications, and leadership. Much of her recent work has been in the cannabis industry, highlighting the potential health benefits of cannabis and CBD. She recently joined Radicle Science as a founding team member and Chief Growth Officer. At its core, …
Alice Moon is a PR and marketing professional who has worked in the cannabis space since 2011. In 2018, Alice was diagnosed with Cannabinoid Hyperemesis Syndrome, a condition that leads to repeated and severe bouts of vomiting when she consumes cannabinoids. Since being diagnosed with CHS, Alice has ceased cannabis use completely and become an advocate for safe and mindful …
Dr. Peter Grinspoon is a primary care physician at Massachusetts General Hospital and an Instructor in Medicine at Harvard Medical School. He is a Contributing Editor to Harvard Health Publications and the Harvard Health Blog, where he frequently writes about cannabis medicine issues. Dr. Grinspoon also writes about addiction, both from the perspective of a clinician treating the disorder and as someone …
We discuss dosing medical cannabis with Dr. Dustin Sulak. Dustin is an osteopathic general practitioner who focuses on treating patients with refractory conditions using an individualized, health-centered approach. Dr. Sulak is a founder of Integr8 Health, a medical practice in Maine that follows over 8,000 patients using medical cannabis, and cofounder of Healer.com, a medical cannabis education resource. Dustin has …
Our latest guest is Professor Raphael Mechoulam. Professor Mechoulam is the first researcher to isolate THC and CBD. For that achievement and the decades of research into the endocannabinoid system that followed, Professor Mechoulam is often called the “Godfather of cannabis research”. Since his research began in the 1960s, Professor Mechoulam has received numerous academic awards. Most recently he received …
Our guest in this episode is Dr. Mauro Maccarrone. Mauro is a pioneer in endocannabinoid research. In 1997, his team identified the receptor targets for the first two endocannabinoids that were discovered by Professor Raphael Mechoulam earlier in the decade: anandamide and 2-AG. Since then, the endocannabinoid system has been the focus of his research. At CannMed 2021 he will present …
Our guest this week is Dr. Staci Gruber, Director of the Cognitive and Clinical Neuroimaging Core at McLean Hospital’s Brain Imaging Center and an Associate Professor of Psychiatry at Harvard Medical School. Dr. Gruber has spent decades investigating how both recreational and medical cannabis use affects the brain. In 2014, Dr. Gruber launched Marijuana Investigations for Neuroscientific Discovery (MIND), the …
